1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>India

P&G To Cut Portfolio In Half, Refocus On Core In Simplification Strategy

 
• By Eileen Francis

P&G will divest or discontinue half its brands and focus on lines that account for 90% of its total sales under a streamlining effort CEO A.G. Lafley says will result in portfolio offering “consumer-preferred and customer supported” products.

Procter & Gamble Co. plans to streamline its business to “consumer preferred and customer supported” offerings by divesting or discontinuing about half of its brands within the next two years.

The strategy aims to whittle down the portfolio from roughly 160 brands to between 70 and 80, President and CEO...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Asia

New Era Begins In Korea: Policy Predictions For Biopharma

 
• By Jung Won Shin

As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.

Australia Looks To Modernize Human Tissue Laws, Improving Access For Researchers

 
• By Eliza Slawther

Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.

China NMPA Lays Out Regulatory Priorities At DIA

 
• By Xu Hu

At this year’s DIA China meeting, the national regulator updated its policy focus areas for this year, including clinical trial data protection and pilot projects to shorten IND approval times.